XomeDx®Prenatal - Targeted

New York

Clinical Utility

  • Establishing a molecular diagnosis in a fetus with abnormal ultrasound findings.

Lab Method

  • Next-Gen Sequencing

Important Information

With a turnaround time (TAT) of 3-4 weeks, the fetal specimen and specimens from both biological parents must be submitted at the same time, along with clinical information, in order to begin testing. This test requires approval by GeneDx before ordering; please e-mail WESPrenatal@genedx.com to discuss cases prior to submitting samples. The XomeDxPrenatal Targeted fetal report will include medically relevant pathogenic or likely pathogenic variants in genes expected to be related to the reported fetal phenotype. Variants of uncertain significance may be reported if there is compelling evidence to suggest clinical significance.

Insurance billing not accepted

Test Code


CPT Codes*

81415x1, 81416x2, 81265x1

ABN Required


Turnaround Time**

3-4 weeks

Preferred Specimen

30 mL Amniotic Fluid

Alternative Specimen

30 mg CVS | 2 T25 flasks of cultured amniocytes | 2 T25 flasks of cultured chorionic villi | 15 µg DNA Concentration

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.